TKNO earnings date and last-quarter result: last quarter in line, P/E -16.28. Updated 2026-07-23.
Alpha Teknova (TKNO) Research Hub
Alpha Teknova (TKNO) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 6.59 USD (+2.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -16.28, market cap 0.28B. This hub links to the full technical, earnings and options research available for TKNO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.59 USD (+2.65%) |
| 52-week range | 4.03 USD – 9.46 USD |
| Trend regime | Range |
| 14-day RSI | 30.8 (Bearish) |
| Trailing P/E | -16.28 |
| Market cap | 0.28B |
| Dividend yield | 0.00% |
Available research for TKNO
Covered Call on TKNO: how it works, illustrative setup around the real 6.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TKNO: how it works, illustrative setup around the real 6.59 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TKNO: how it works, illustrative setup around the real 6.59 USD price, max profit/loss, breakeven and when to use it. Educational.
TKNO technical analysis: range, last 6.59 USD, RSI 30.8, 52w range 4.03 USD–9.46 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TKNO in?
Alpha Teknova (TKNO) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is TKNO in an uptrend or downtrend?
As of 2026-10-26, TKNO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TKNO's trailing P/E ratio?
TKNO's trailing P/E is -16.28, with a market cap of 0.28B. See the earnings research page for full valuation detail.